A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population

[1]  P. Burton,et al.  A genomewide linkage study of 1,933 families affected by premature coronary artery disease: The British Heart Foundation (BHF) Family Heart Study. , 2005, American journal of human genetics.

[2]  Silke Schmidt,et al.  A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. , 2004, American journal of human genetics.

[3]  S. Ley,et al.  Functions of NF-?B1 and NF-?B2 in immune cell biology , 2004 .

[4]  S. Martinotti,et al.  A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. , 2004, JAMA.

[5]  Yusuke Nakamura,et al.  Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-α secretion in vitro , 2004, Nature.

[6]  S. Gabriel,et al.  Assessing the impact of population stratification on genetic association studies , 2004, Nature Genetics.

[7]  J. Gulcher,et al.  The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke , 2004, Nature Genetics.

[8]  Eric J Topol,et al.  Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis. , 2004, American journal of human genetics.

[9]  E. Topol,et al.  Mutation of MEF2A in an Inherited Disorder with Features of Coronary Artery Disease , 2003, Science.

[10]  K. Buetow,et al.  Allelic variation in gene expression is common in the human genome. , 2003, Genome research.

[11]  P. Elliott,et al.  Proteasome inhibition: a new anti-inflammatory strategy , 2003, Journal of Molecular Medicine.

[12]  M. Olivier.  A haplotype map of the human genome. , 2003, Nature.

[13]  M. Olivier.  A haplotype map of the human genome , 2003, Nature.

[14]  P. Elliott,et al.  Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury. , 2003, American journal of physiology. Heart and circulatory physiology.

[15]  Weiping Ma,et al.  Embryogenesis Microarray for Profiling Gene Expression Patterns during 15,000 Unique Zebrafish Est Clusters and Their Future Use in Material Supplemental , 2022 .

[16]  H. Izawa,et al.  Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. , 2002, The New England journal of medicine.

[17]  Hiroshi Sato,et al.  Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction , 2002, Nature Genetics.

[18]  Yusuke Nakamura,et al.  Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190 562 genetic variations in the human genome , 2002, Journal of Human Genetics.

[19]  A. Tonkin,et al.  Genome-Wide Linkage Analysis of the Acute Coronary Syndrome Suggests a Locus on Chromosome 2 , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[20]  P. Kloetzel,et al.  Ubiquitin-Proteasome Pathway as a New Target for the Prevention of Restenosis , 2002, Circulation.

[21]  M. Daly,et al.  Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. , 2000, American journal of human genetics.

[22]  Michael Karin,et al.  The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling , 2000 .

[23]  S. Antonarakis,et al.  Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion , 2000 .

[24]  J. Pritchard,et al.  Use of unlinked genetic markers to detect population stratification in association studies. , 1999, American journal of human genetics.

[25]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[26]  A. Zeiher,et al.  Dephosphorylation Targets Bcl-2 for Ubiquitin-dependent Degradation: A Link between the Apoptosome and the Proteasome Pathway , 1999, The Journal of experimental medicine.

[27]  S. Salghetti,et al.  Destruction of Myc by ubiquitin‐mediated proteolysis: cancer‐associated and transforming mutations stabilize Myc , 1999, The EMBO journal.

[28]  P. Howley,et al.  In vivo ubiquitination and proteasome-mediated degradation of p53(1). , 1996, Cancer research.

[29]  A. Ciechanover,et al.  The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extended. , 2004, Cardiovascular research.

[30]  Lisa J. Martin,et al.  A comprehensive linkage analysis for myocardial infarction and its related risk factors , 2002, Nature Genetics.

[31]  K Tanaka,et al.  Structure and functions of the 20S and 26S proteasomes. , 1996, Annual review of biochemistry.

[32]  D. Beech.  A discussion , 1979 .